151230-42-1

Basic information

• Product Name: 6-BROMO-2-METHYLBENZODOXAZOLE
• Synonyms: 6-BROMO-2-METHYLBENZODOXAZOLE;6-BROMO-2-METHYLBENZOXAZOLE;6-BroMo-2-Methyl-1,3-benzoxazole;6-Bromo-2-methyl-benzooxazole;Benzoxazole, 6-bromo-2-methyl-
• CAS NO: 151230-42-1
• Molecular Formula: C₈H₆BrNO
• Molecular Weight: 212.04
• Mol File: 151230-42-1.mol
• Article Data: 8

Chemical Properties

• Melting Point: 44-49°C
• Boiling Point: 264.8±13.0 °C(Predicted)
• Flash Point: >110℃
• Appearance: /
• Density: 1.606±0.06 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: -0.09±0.30(Predicted)
• CAS DataBase Reference: 6-BROMO-2-METHYLBENZODOXAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BROMO-2-METHYLBENZODOXAZOLE(151230-42-1)
• EPA Substance Registry System: 6-BROMO-2-METHYLBENZODOXAZOLE(151230-42-1)

Safety Data

• Hazard Codes: Xn
• Statements: 22-37/38-41
• Safety Statements: 26-39
• WGK Germany: 3
• Hazardous Substances Data: 151230-42-1(Hazardous Substances Data)

Usage

General Description

6-BROMO-2-METHYLBENZODOXAZOLE is a chemical compound with a molecular formula C8H6BrNO. It is a benzodoxazole derivative that contains a bromine atom and a methyl group attached to a benzene ring. This chemical is commonly used as a building block in organic synthesis and medicinal chemistry research. Its unique structure and reactivity make it a valuable intermediate in the production of pharmaceuticals, agrochemicals, and materials science. Additionally, 6-BROMO-2-METHYLBENZODOXAZOLE may also have potential applications in the development of new drugs and materials due to its interesting chemical properties.

Upstream product

• 1095544-88-9 1-(4-bromo-2-hydroxyphenyl)ethanone oxime 
• 38191-34-3 2-amino-5-bromophenol 
• 78-39-7 Triethyl orthoacetate 
• 1445-45-0 Trimethyl orthoacetate 
• 16394-40-4 N-(4-bromo-2-hydroxyphenyl)acetamide 

Downstream Products

• 61309-99-7 2-Methyl-6-phenylbenzoxazole 
• 1312435-75-8 C₁₇H₁₅NO₃ 
• 1618658-88-0 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-N-methylbenzamide 
• 1618660-48-2 4-((4-cyclobutoxy-5-(2-methylbenzo[d]oxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-N-methylbenzamide 
• 1618660-02-8 4-(4-cyclopropoxy-5-(2-methylbenzo[d]oxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-3-methoxy-N-methylbenzamide 
• 1618659-75-8 4-(4-isopropoxy-5-(2-methylbenzo[d]oxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-3-methoxy-N-methylbenzamide 
• 1618660-18-6 4-((4-(2-hydroxyethoxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-N-methylbenzamide 
• 1618660-29-9 3-methoxy-N-methyl-4-((5-(2-methylbenzo[d]oxazol-6-yl)-4-(oxetan-3-yloxy)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)benzamide 
• 1618660-19-7 (S)-3-methoxy-N-methyl-4-((5-(2-methylbenzo[d]oxazol-6-yl)-4-((tetrahydrofuran-3-yl)oxy)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-amino)benzamide 
• 1618659-40-7 3-methoxy-N-methyl-4-((5-(2-methylbenzo[d]oxazol-6-yl)-4-((tetrahydro-2H-pyran-4-yl)oxy)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-amino)benzamide 

Relevant articles and documents

Multicatalytic Beckmann rearrangement of 2-hydroxylarylketone oxime: Switchable synthesis of benzo[d]oxazoles and N-(2-hydroxylaryl)amides

A switchable synthesis route is developed for benzo[d]oxazole derivatives and (2-hydroxylaryl)benzamide from 2-hydroxylbenzeneketoxime using organomolecules (BOP-Cl, and CNC) and Lewis acid cocatalyzed Beckmann rearrangement (BR) reaction. Further, this reaction is switched using different organocatalysts.

RADIOACTIVE IODINE LABELED STYRYL SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUND

PROBLEM TO BE SOLVED: To provide a novel tau protein imaging agent that allows imaging of biological tau protein by a noninvasive, nuclear medical method. SOLUTION: The present invention provides a radioactive iodine labeled styryl substituted aromatic heterocyclic compound represented by a predetermined general formula or a salt thereof, or a radioactive medicine comprising the same. SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT

NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.